Chronic Lymphocytic Lymphoma
3 clinical trials · Condition
◉ Watch Chronic Lymphocytic Lymphoma
| Record | Firm | Date |
|---|---|---|
| Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies (NCT04599634) | National Cancer Institute (NCI) | 2021-12-16 |
| Host Dendritic Cells in Allograft Patients (NCT00935597) | Icahn School of Medicine at Mount Sinai | 2009-08-01 |
| Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in CLL (NCT00603668) | Gilead Sciences | 2008-08-01 |
Track Chronic Lymphocytic Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.